The first decision confronting clinicians in the management of patients with community acquired pneumonia (CAP) is whether the patient is to be hospitalized or not. We sought to validate the pneumonia scoring system and assess the power of procalcitonin (PCT) level to predict in-hospital mortality (IHM) and intensive vasopressor and respiratory support (IVRS) requirements in patients with CAP. Materials and Methods: A total of 120 patients with CAP were evaluated for severity of illness based on the defined scoring systems including pneumonia severity index (PSI), confusion, urea, respiratory rate, blood pressure, age>65 (CURB-65), confusion, respiratory rate, blood pressure, age>65 (CRB-65), infectious diseases society of America/American thoracic society 2007 criteria (IDSA/ATS 2007) and systolic blood pressure, multilobar infiltrate, albumin, respiratory rate, tachycardia, confusion, low oxygen, low pH (SMART-COP).Demographic, clinical, laboratory and radiographic data were collected prospectively. The accuracy of each scoring system in predicting IVRS requirement and IHM was assessed from the area under the receiver operating characteristic (ROC) curve (AUC). Level of PCT was determined by semiquantitative PCT-Q method (BRAHMS). The accuracy of the defined scoring systems, PCT levels and each scoring system plus PCT levels in prediction of IHM and IVRS requirement was analyzed. Results: The accuracy of PCT levels in predicting IHM and IVRS requirement based on AUC was 0.542 and 0.658, respectively and the best threshold was ≥ 2ng/mL for both of them. Adding the level of procalcitonin to different scoring systems (based on the defined scoring systems) improved the accuracy of all systems. Conclusion: We do not suggest using the PCT level alone as a predictor for mortality and IVRS requirement. Instead, we suggest PSI plus PCT and IDSA/ATS 2007 plus PCT as accurate predictors for IHM and SMART-COP plus PCT for IVRS requirement in patients who presented with CAP.
INTRODUCTION
The initial management decision after diagnosis of CAP is to determine the site of care. There is significant variation in admission rates among hospitals and among individual physicians. Overestimation of the severity of CAP is common among physicians and leads to hospitalization of a significant number of patients at low risk for death. Because of this, different specialty groups have tried to develop objective site-of-care criteria or severity scoring systems (1) . Several scoring systems have been proposed. These scoring systems include PSI (20 In addition, several inflammatory markers were identified with predictive capacity of the severity of pneumonia. Among the most widely studied biomarkers are C-reactive protein (CRP) and PCT (7) (8) (9) (10) (11) .
Herein, we conducted a study to validate each scoring system and assessed the level of serum procalcitonin for prediction of IHM and IVRS requirement alone and in combination with other severity scoring systems in adult patients with CAP.
MATERIALS AND METHODS

Selection and Description of Participants
Out of 166 patients with community acquired lower respiratory tract problems with chest infiltrate, 140 cases were eligible for this study. Sixteen patients with noninfectious etiologic diagnosis and four patients with extrapulmonary infections were excluded from the study. This study was approved by the vice chancellery, the institutional review board (IRB) and ethics committee of Mashhad University of Medical Sciences (MUMS). Written informed consents were taken from all subjects.
Technical Information
All patients underwent a diagnostic evaluation, including chest radiography with/without chest computed The PCT level factor of each scoring system as a risk factor for IHM and IVRS requirement was considered and calculated by the AUC of each new model. Patients included in our study were those who had new infiltrates on chest radiography with fever or lower respiratory signs/symptoms, (or both) and required hospital admission.
Chronic obstructive pulmonary disease (COPD) was defined clinically as the presence of a chronic productive cough for ≥ three months during two consecutive years (other causes of cough being excluded).
Bedridden status was defined as confined to bed by sickness or old age.
Opium addiction was defined as behaviors that include one or more of the following: Impaired control over drug (opioid) use, compulsive drug use or continued use.
Statistical Analyses
Statistical analyses were performed using SPSS software and R programming language. Discrete variables were expressed as percentage and continuous variables as mean ± standard deviation (SD) unless stated otherwise. The sensitivity and specificity of each score at the best threshold and after adding PCT levels to each score were calculated using R programming language.
RESULTS
One hundred twenty patients fulfilled the criteria for inclusion. The mean age was 50.4 ± 22.6 years (range 17-94). The male to female ratio was 1/7. The most common microbial diagnosis was S. pneumonia, followed by M. The associations of PCT levels with IHM and IVRS requirement were also analyzed and showed different levels of PCT; the odds ratio values for IHM were 2.95, 1.467 and 0.595 for PCT level>10ng/mL, >2ng/mL and >0.5ng/mL, respectively. The associations for IVRS requirement were: 6.846, 3.555, and 1.136 for PCT level>10ng/mL, >2ng/mL, and >0.5ng/mL, respectively (Table 2) .
Comparison of PCT levels in patients with CAP of different levels of severity showed that the PCT levels increased with increasing severity of CAP according to PSI, CURB-65, SMART-COP, and IDSA/ATS scores (Table 3) and CURB-65) and death within a month all tend to correlate with higher PCT, no definite cut-off was found, and PCT should always be interpreted carefully (25) . Based on the results of our study, in comparison with the defined severity scores, PCT level alone is a week predictor of pneumonia severity.
In the second arm of the study, we added the PCT level factor to each scoring system as a risk factor for IHM and However, the present study has also some limitations, such as the limited number of patients, single-center design, assessment of hospitalized patients only and semiquantitative technique for measuring PCT levels. In addition, because of the limited number of ICU beds, the number of patients admitted to the ICU was far less than the actual number of patients who needed intensive care.
The difference in the efficacy and quality of intensive care among patients with severe illness could be a potential confounder in our study. Further large-scale, randomized controlled trials are recommended.
